Systematic Review: Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome is associated with reduced risk of death or bronchopulmonary dysplasia, less intubation in the first 72 hours, and reduced incidence of major complications and in‐hospital mortality.

Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome – Cochrane Library

Summary: Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome – Cochrane Library

Commentary on Twitter

Is giving surfactant via minimally invasive technique involving placement of a thin catheter in the trachea of a spontaneously breathing #infant effective and safe? https://t.co/0TKceRx4Oh New #SystematicReview from @CochraneNeonate looks at the evidence from 6 randomised trials. pic.twitter.com/qPB3Q0vp9E

— Cochrane UK (@CochraneUK) May 15, 2021